PT  - JOURNAL ARTICLE
AU  - Snyder, Robert E.
AU  - Saadeh, Kayla
AU  - Tang, Eric C.
AU  - Johnson, Kelly A.
AU  - Holland, Samuel N.
AU  - Quint, Joshua
AU  - Burghardt, Nicole O.
AU  - Chai, Shua J.
AU  - Fernando, Roshani
AU  - Gonzalez Barrera, Kimberly
AU  - Hernandez, Cindy
AU  - McManus, Korie
AU  - Lorenz, Kieran
AU  - Maycott, Jarett
AU  - McGinley, John
AU  - Lewnard, Joseph A.
TI  - Sexual exposures associated with mpox infection: California, November 2022 to June 2023
AID  - 10.1101/2023.08.07.23293793
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.07.23293793
4099  - http://medrxiv.org/content/early/2023/08/09/2023.08.07.23293793.short
4100  - http://medrxiv.org/content/early/2023/08/09/2023.08.07.23293793.full
AB  - Background Exposures associated with mpox infection remain imperfectly understood.Methods We conducted a case-control study enrolling participants who received molecular tests for mpox/orthopoxvirus in California from November 2022 through June 2023. We collected data on behaviors during a 21-day risk period before symptom onset or testing among mpox cases and test-negative controls.Results Thirteen of 54 (24.1%) cases and 5/117 (4.3%) controls reported sexual exposure to individuals they identified as potential mpox cases (“index contacts”; odds ratio [OR]=7.7 [95% confidence interval: 2.5-19.3]). Among these participants, 10/13 (76.9%) cases and 2/5 (40.0%) controls reported their index contacts were not experiencing symptoms visible to participants during sex (OR=14.9 [3.6-101.8]). Only 3/54 cases (5.6%) recalled exposure to symptomatic index contacts. Cases reported greater numbers of anal/vaginal sex partners than controls (adjusted OR=2.2 [1.0-4.8] for 2-3 partners and 3.8 [1.7-8.8] for ≥4 partners). Male cases with penile lesions more commonly reported insertive anal/vaginal sex than those without penile lesions (adjusted OR=9.3 [1.6-54.8]). Cases with anorectal lesions more commonly reported receptive anal sex than cases without anorectal lesions (adjusted OR=14.4 [1.0-207.3]).Conclusions Sexual exposure to contacts known or suspected to have experienced mpox was associated with increased risk of infection, often when index contacts lacked apparent symptoms. Exposure to greater numbers of sex partners, including those whom participants did not identify as index contacts, was associated with increased risk of infection in a site-specific manner. While participants’ assessment of symptoms in partners may be imperfect, these findings suggest individuals without visibly prominent mpox symptoms transmit infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the CDC Strengthening STD Prevention and Control for Health Departments (STD PCHD) cooperative agreement (PS19-1901 to the California Department of Public Health STD Control Branch) and the National Institute of Allergy and Infectious Diseases (R01-AI14812701 to JAL).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As a routine public health surveillance activity, the study was considered exempt from human subjects review by the Committee for the Protection of Human Subjects of the State of California Health and Human Services Agency (project number 2022-201).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDe-identified data that underlie the results reported in this article will be made available upon reasonable request to the authors.